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Abstract. 
 
In the present study, we present evidence 
about the cellular functions of KIF2, a kinesin-like su-
perfamily member having a unique structure in that its 
motor domain is localized at the center of the molecule 
(Noda Y., Y. Sato-Yoshitake, S. Kondo, M. Nangaku, 
and N. Hirokawa. 1995. 
 
J. Cell Biol.
 
 129:157–167.). Us-
ing subcellular fractionation techniques, isopicnic su-
crose density centrifugation of microsomal fractions 
from developing rat cerebral cortex, and immunoisola-
tion with KIF2 antibodies, we have now identified a 
type of nonsynaptic vesicle that associates with KIF2. 
This type of organelle lacks synaptic vesicle markers 
(synapsin, synaptophysin), amyloid precursor protein, 
GAP-43, or N-cadherin. On the other hand, it contains 
 
b
 
gc
 
, which is a novel variant of the 
 
b
 
 subunit of the IGF-1 
receptor, which is highly enriched in growth cone mem-
branes. Both 
 
b
 
gc
 
 and KIF2 are upregulated by NGF in 
PC12 cells and highly concentrated in growth cones of 
developing neurons. We have also analyzed the conse-
quences of KIF2 suppression by antisense oligonucle-
otide treatment on nerve cell morphogenesis and the 
distribution of synaptic and nonsynaptic vesicle mark-
ers. KIF2 suppression results in a dramatic accumula-
tion of 
 
b
 
gc
 
 within the cell body and in its complete dis-
appearance from growth cones; no alterations in the 
distribution of synapsin, synaptophysin, GAP-43, or 
amyloid percursor protein are detected in KIF2-sup-
pressed neurons. Instead, all of them remained highly 
enriched at nerve terminals. KIF2 suppression also pro-
duces a dramatic inhibition of neurite outgrowth; this 
phenomenon occurs after 
 
b
 
gc
 
 has disappeared from 
growth cones. Taken collectively, our results suggest an 
important role for KIF2 in neurite extension, a phe-
nomenon that may be related with the anterograde 
transport of a type of nonsynaptic vesicle that contains 
as one of its components a growth cone membrane re-
ceptor for IGF-1, a growth factor implicated in nerve 
cell development.
 
D
 
uring
 
 recent years it has become increasingly evi-
dent that the assembly of the neuronal cytoskele-
ton and the transport of membrane precursors to
the active growing tip of neuritic processes are the two ba-
sic events underlying process formation in developing neu-
rons (Mitchison and Kirschner, 1988; Tanaka and Sabry,
1995). Because axons and their growth cones lack protein
synthetic machinery, highly specialized intracellular trans-
port mechanisms must exist to deliver appropriate cargoes
to their final destinations and/or to sites of membrane ad-
dition.
The microtubule-based anterograde fast axonal trans-
port is one of the mechanisms by which tubulovesicular
structures, synaptic membrane precursors, and nonsynap-
tic membrane-bound organelles are distributed along ax-
onal processes (Hirokawa, 1996). Kinesin, the first discov-
ered and characterized anterograde microtubule-based
motor (Brady, 1985; Scholey et al., 1985; Vale et al.,
1985a), has been involved in the transport of tubulovesicu-
lar organelles such as the endoplasmic reticulum (Feiguin
et al., 1994), endosomes and lysosomes (Hollenbeck and
Swanson, 1990; Feiguin et al., 1994; Nakata and Hirokawa,
1995), as well as of certain groups of vesicles containing
GAP-43, synapsin I, and amyloid precursor protein (Fer-
reira et al., 1992, 1993). However, recent studies have pro-
vided evidence indicating that kinesin is not the only an-
terograde microtubule-based motor involved in organelle
transport within axons. Thus, molecular genetic approaches
have identified a series of gene-encoding proteins sharing
a domain of 350 amino acids, which contains a putative
ATP-binding site and a microtubule-binding domain ho-
mologous to that of kinesin heavy chain (for reviews see
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Endow, 1991; Goldstein, 1991; Hirokawa, 1993, 1996). In
the particular case of murine brain tissue, a systematic
search for novel putative motors led to the initial discov-
ery of 11 members of the kinesin superfamily (Aizawa et
al., 1992; Kondon et al., 1994; Okada et al., 1995; Noda et
al., 1995; Yamazaki et al., 1995; Hirokawa, 1996). More
importantly, the function of at least some of these proteins
has already been established. For example, KIF1A, the
murine homologue of unc104 kinesin (Hall and Hedge-
cock, 1991), is a monomeric motor involved in the antero-
grade transport of synaptic vesicle precursors (Okada et
al., 1995), while mitochondria are conveyed anterogradely
by KIF1B (Nangaku et al., 1994).
KIF2 is one kinesin superfamily member having a
unique structure in that its motor domain is localized at
the center of the molecule (Aizawa et al., 1992; Noda et
al., 1995). There is considerable interest in defining KIF2
function since this molecule may have an important role in
the transport of membranous organelles to the active
growing tip of axonal processes. Thus, KIF2 is predomi-
nantly expressed in developing brain tissue, where it is
highly enriched in growth cones and appears to be special-
ized for the transport of membranous organelles different
from those carried by kinesin heavy chain (KHC),
 
1
 
 KIF1A
(Okada et al., 1995), KIF1B (Nangaku et al., 1994), or
KIF3A/B (Noda et al., 1995).
With these considerations in mind, in the present study
we examined the cellular functions of KIF2 in mammalian
neurons. To approach this problem, subcellular fraction-
ation techniques and immunoisolation experiments of
membrane organelles with antibodies against KIF2 were
initially used to obtain some insight about the nature of
the cargo that KIF2 may transport. We then analyzed the
pattern of expression, subcellular localization, and conse-
quences of KIF2 suppression by antisense oligonucleotide
treatment on the distribution of several growth cone mem-
brane proteins and neurite outgrowth in PC12 cells. Taken
collectively, the results obtained suggest an important role
for KIF2 in neurite extension, a phenomenon that may be
related with the anterograde transport of a type of nonsyn-
aptic vesicle that contains as one of its components a
growth cone membrane protein designated 
 
b
 
gc
 
, which is a
novel variant of the 
 
b
 
 subunit of the IGF-1 receptor
(Quiroga et al., 1995; Mascotti et al., 1997).
 
Materials and Methods
 
Cultures
 
The rat pheochromocytoma cell line (PC12 cells) was obtained from Dr.
Adriana Ferreira (Center Neurological Diseases, Harvard Medical
School, Boston, MA). They were grown on DME supplemented with 10%
horse serum. Cells were plated onto polylysine-treated glass coverslips
(Mascotti et al., 1997) at densities ranging from 5,000–20,000 cells/cm
 
2
 
. 2 d
after plating, the coverslips with the attached cells were transferred to
Petri dishes containing serum-free medium supplemented with the N
 
2
 
mixture of Bottenstein and Sato (1979). To induce the differentiation of
PC12 cells, NGF (Boehringer Mannheim Chemicals, Indianapolis, IN)
was added to the culture medium at a concentration of 50 ng/ml.
 
Antisense Oligonucleotides
 
Antisense phosphorothioate oligonucleotides (S-modified) were used in
the present study. The initial experiments were performed with oligonu-
cleotides 
 
2
 
11/
 
1
 
14 of the sequence of mouse KIF2 (Aizawa et al., 1992;
Noda et al., 1995). However, because, PC12 cells are of rat origin, these
experiments were subsequently repeated using oligonucleotides corre-
sponding to the rat KIF2 sequence. The rat sequence in the region of the
KIF2 motor domain was obtained by using nondegenerate, 18-mer mouse
primers, and performing PCR on reverse-transcribed rat brain mRNA.
An amplified band of the expected size was obtained and the DNA was
cloned and sequenced. Analysis of the obtained sequence revealed 
 
.
 
96%
homology with the reported sequence of mouse KIF2 (Noda et al., 1995).
One of the oligonucleotides designated ASKF2a corresponds to the se-
quence ACACTGCATGGCTCCGAGATG, and is the inverse comple-
ment of nucleotides 
 
1
 
830/851 of the sequence of the motor domain of rat
KIF2; antisense oligonucleotide ASKF2b, consisting of the sequence
CACTGCATGGCTCCG, is the inverse complement of the rat nucle-
otides 
 
1
 
831/845. Both of the regions selected from the sequence of the rat
KIF2 motor domain are identical to the corresponding regions in the
mouse KIF2 sequence.
The oligonucleotides were purchased from Quality Controlled Bio-
chemicals (Hopkinton, MA); they were purified by reverse chromatogra-
phy, and taken up in serum-free medium as described previously (Cáceres
and Kosik, 1990; DiTella et al., 1996). For all the experiments the anti-
sense oligonucleotides were preincubated with 2 
 
m
 
l of lipofectin reagent
(1 mg/ml; GIBCO BRL, Gaithersburg, MD) diluted in 100 
 
m
 
l of serum-
free medium. The resulting oligonucleotide suspension was then added to
the NGF-treated PC12 cells at concentrations ranging from 1–5 
 
m
 
M. Con-
trol cultures were treated with the same concentration of the correspond-
ing sense-strand oligonucleotides. For some experiments, PC12 cells were
treated for 1 d with a nonmodified KHC antisense oligonucleotide desig-
nated 
 
2
 
11/
 
1
 
14 hkin (Ferreira et al., 1992, 1993; Feiguin et al., 1994) in or-
der to suppress KHC expression; this antisense oligonucleotide was used
at a concentration of 50 
 
m
 
M.
The administration of all oligonucleotides was as follows: after PC12
cells have differentiated in the presence of NGF for 3 d, the oligonucle-
otides were added to the culture medium. The medium was then supple-
mented with additional oligonucleotide every 12 h until the end of the ex-
periment.
 
Primary Antibodies
 
The following primary antibodies were used in this study: an mAb against
all isoforms of 
 
b
 
-tubulin (clone DM1B, mouse IgG; Sigma Chemical Co.,
St. Louis, MO) diluted 1:100; an mAb against tyrosinated 
 
a
 
-tubulin (clone
TUB-1A2, mouse IgG; Sigma Chemical Co.) diluted 1:2,000; an mAb
against KHC (clone SUK4; Ingold et al., 1988) diluted 1:10; an mAb
against synaptophysin (clone SY38, mouse IgG; Boehringer Mannheim
Biochemicals) diluted 1:100; an mAb against GAP-43 (clone 9-1E12; Gos-
lin and Banker, 1990) diluted 1:1,000; an mAb against the amyloid precur-
sor protein (Boehringer Mannheim Biochemicals) diluted 1:50; an mAb
against N-cadherin (clone GC4; Sigma Chemical Co.) diluted 1:100; an af-
finity-purified rabbit polyclonal antibody against synapsin I (a generous
gift of Dr. A. Ferreira) diluted 1:50; and an affinity-purified rabbit poly-
clonal antibody against 
 
b
 
gc
 
 (Quiroga et al., 1995; Mascotti et al., 1997) di-
luted 1:100. In addition, we generated two peptide antibodies against KIF2.
One peptide corresponds to amino acid residues 526–535 of mouse KIF2,
while the other corresponds to amino acids 114–123 of the same KIF2 mole-
cule. The peptides were coupled to keyhole limpet hemacyanin (KLH;
Sigma Chemical Co) using glutaraldehyde as cross-linker. After emulsifi-
cation with Freund’s adjuvant (GIBCO BRL, Gaithersburg, MD), the re-
sultant compounds were injected into rabbits at doses of 0.5 mg. On the
third day after the third booster, the rabbits were bled from the ear, the
serum was then affinity purified using a protein A column.
 
Western Blot Analysis
 
Equal amounts of crude brain homogenates or whole cell extracts from
PC12 cells were fractionated on 7.5% SDS-PAGE and transferred to po-
livinylidene difluoride (PVDF) membranes in a Tris–glycine buffer, 20%
methanol. The filters were dried, washed several times with TBS (10 mM
Tris, pH 7.5, 150 mM NaCl), and blocked for 1 h in TBS containing 5%
BSA. The filters were incubated for 1 h at 37
 
8
 
 C with the primary antibod-
ies in TBS containing 5% BSA. The filters were then washed three times
(10 min each) in TBS containing 0.05% Tween 20, and incubated with a
 
1. 
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secondary alkaline phosphatase-conjugated antibody (ProtoBlot Western
Blot Alkaline Phosphatase System; Promega Corp., Madison, WI) for 1 h
at 37
 
8
 
C. After five washes with TBS and 0.05% Tween 20, the blots were
developed with bromochloro-iodolylphosphate (15 
 
m
 
l of a 50 mg/ml stock
solution) and nitroblue-tetrazolium (2.5 
 
m
 
l of a 75 mg/ml stock solution)
in 10 ml of alkaline phosphatase detection buffer (100 mM Tris, 100 mM
NaCl, 5 mM MgCl
 
2
 
, pH 9.5). In addition, KIF2 protein levels were mea-
sured by quantitative immunoblotting as described by Drubin et al., 1985
(see also DiTella et al., 1996). For such a purpose, immunoblots were
probed with the corresponding primary antibody, followed by incubation
with 
 
125
 
I-protein A. Autoradiography was performed on Kodak X-omat
AR film (Eastman Kodak Co., Rochester, NY) using intensifying screens.
Autoradiographs were aligned with immunoblots and KIF2 protein levels
were quantitated by scintillation counting of nitrocellulose blot slices.
 
Preparation of Microtubules from Cytosolic Fractions
 
For some experiments, microtubules were prepared from cytosolic frac-
tions obtained from the cerebral cortex of 7-d-old rats by the method of
Vallee (1982) in the presence or absence of AMP-PNP. The association of
KIF2 with microtubules was then evaluated by Western blotting of the mi-
crotubule pellet using the anti-KIF2 antibodies. In an additional set of ex-
periments, microtubule pellets were incubated with 10 mM ATP and 100
mM NaCl to release KIF2 from the microtubules. The presence of KIF2 in
the supernatant was also assessed by Western blotting.
 
Subcellular Fractionation and Sucrose Density 
Gradient Centrifugation
 
Multiple fractions from 3-d-old rat cerebral cortex were prepared accord-
ing to standard procedures (see Ueda et al., 1979; Kondo et al., 1994).
Briefly, rat cerebral cortex was gently homogenized with 10
 
3
 
 vol of ice-cold
0.32 M sucrose, 10 mM Hepes, pH 7.4. The homogenate was centrifuged
at low speed (3,000 
 
g
 
) for 10 min at 4
 
8
 
 C. The supernatant was centrifuged
at medium speed (9,200 
 
g
 
) for 15 min. The medium speed supernatant was
again centrifuged at high speed (100,000 
 
g
 
) for 60 min to yield a cytosolic
fraction (Fig. 1, 
 
S3
 
) and a microsomal one (Fig. 1, 
 
P3
 
). All the obtained
fractions (supernatants and pellets) were then subjected to electrophore-
sis, transferred to PVDF membranes, and probed with the antibodies
against KIF2. For some experiments, the microsomal fraction was further
applied to a 0.3–1.6 M sucrose density gradient at 48,000 rpm for 2 h in a
Sorvall STS 60.4 rotor (Sorvall Instruments, Newtown, CT). 0.3-ml frac-
tions were collected from 4-ml tubes; they were then centrifuged at
100,000 
 
g
 
, and the resulting pellets resuspended in Laemmli buffer. The
same volume from each fraction was applied to SDS-PAGE and trans-
ferred to PVDF membrane. Fractions were then analyzed by immunoblot-
ting with antibodies against KIF2, KHC, synaptic vesicle markers, and
growth cone membrane components.
 
Immunoisolation of KIF2-containing Organelles
 
Immunoisolation of KIF2-containing organelles was performed as de-
scribed by Okada et al. (1995). Thus, for this experiment anti-KIF2 anti-
bodies were covalently attached to protein A–Sepharose beads via dimeth-
ylpimelumidate. Microsomal fractions were incubated with these beads at
4
 
8
 
C for 6 h, and the beads were recovered by centrifugation (5,000 rpm for
120 s), and washed with 20 mM Hepes, 100 mM K-aspartate, 40 mM KCl,
5 mM EGTA, 5 mM MgCl
 
2
 
, 2 mM Mg-ATP, 1 mM DTT, pH 7.2, supple-
mented with several protease inhibitors. The supernatant was spun down
(75,000 rpm for 30 min) to collect the remaining organelles. Immunoblot-
ting was then performed as previously described with antibodies against
 
b
 
gc
 
, KHC, synaptophysin, synapsin I, and amyloid precursor protein
(APP).
 
Immunofluorescence
 
Cells were fixed before detergent extraction and processed for immuno-
fluorescence as previously described (DiTella et al., 1996). The antibody
staining protocol entailed labeling with the first primary antibody, wash-
ing with PBS, staining with labeled secondary antibody (fluorescein- or
rhodamine-conjugated) and washing similarly; the same procedure was re-
peated for the second primary antibody. Incubations with primary anti-
bodies were for 1 or 3 h at room temperature, while incubations with sec-
ondary antibodies were performed during 1 h at 37
 
8
 
C. The cells were
observed with an inverted microscope (Axiovert 35M; Carl Zeiss, Inc.,
Thornwood, NY) equipped with epifluorescence and differential interfer-
ence contrast (DIC) optics and photographed using either a 
 
3
 
40, a 
 
3
 
63 or
 
3
 
100 objective (Carl Zeiss, Inc.) with Tri X-Pan or T-MAX 400 ASA film
(Eastman Kodak Co.). Exposures times ranged from 45 to 60 s.
 
Morphometric Analysis of Neuronal Shape Parameters
 
Images were digitized on a video monitor using Metamorph/Metafluor
software (Image Universal Co.). To measure neurite length, fixed, un-
stained, or antibody-labeled cells were randomly selected and traced from
a video screen using the morphometric menu of the Metamorph as de-
scribed previously (DiTella et al., 1996). All measurements were per-
formed using DIC optics at a final magnification of 
 
3
 
768. Differences
among groups were analyzed by the use of ANOVA and Student-New-
man Keuls test. 
 
Results
 
Characterization of the Peptide Antibodies
Against KIF2
 
The monospecificity of the affinity-purified rabbit poly-
clonal antibody (BKF2) raised against a peptide corre-
sponding to amino acid residues 526–535 of mouse KIF2 is
shown in Fig. 1 
 
A.
 
 This antibody recognizes a single band
of 
 
z
 
97 kD in Western blots of whole cell homogenates
from the cerebral cortex of developing rats (Fig. 1 
 
A
 
, lane
 
1
 
); an identical staining pattern is observed when equiva-
lent blots are reacted with RKF2, a rabbit polyclonal anti-
body raised against a peptide corresponding to amino acid
residues 114–123 of the KIF2 molecule (Fig. 1 
 
A
 
, lane 
 
3
 
).
The staining generated by these antibodies is completely
abolished by neutralization with the corresponding puri-
fied peptides (Fig. 1 
 
A
 
, lanes 
 
2
 
 and 
 
4
 
).
Fig. 1 
 
B
 
 shows that in the cerebral cortex the expression
of the BKF2 immunoreactive protein species is higher at
early postnatal days, declining gradually but considerably
until adulthood, where the lowest levels are detected. In
addition, Western blot analysis of subcellular fractions ob-
tained from the cortex of 3-d-old rats revealed that the 97-
kD protein is relatively concentrated in the microsomal
fraction compared with the cytosol or the mitochondrial
fraction (Fig. 1 
 
C
 
). This means that a considerable amount
of the protein recognized by the BKF2 antibody is associ-
ated with small membranous organelles, but only barely
associated with larger ones such as mitochondria (Fig. 1
 
C
 
). In addition, microtubule binding experiments show
that in the absence of ATP, the 97-kD protein cosediments
with taxol-stabilized microtubules obtained from the cere-
bral cortex (Fig. 1 
 
D
 
). This binding occurs in the presence
(Fig. 1 
 
D
 
) or absence (not shown) of AMP-PNP; on the
other hand, the 97-kD protein is released from microtu-
bules incubated with 10 mM ATP plus 100 mM NaCl, but
not in the presence of ATP alone (Fig. 1 
 
D
 
).
Since all the properties described above are identical to
those previously reported for KIF2 (see Noda et al., 1995),
we conclude that our antibodies effectively recognize
KIF2 and not a different protein having a similar molecu-
lar weight.
 
Subcellular Distribution of KIF2
 
To begin analyzing the type of cargo that KIF2 may trans-
port, microsomal fractions from rat cerebral cortex were
fractionated by isopicnic sucrose density gradient centrifu- 
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gation and analyzed by immunoblotting with antibodies
against KIF2, KHC, and several membrane proteins, includ-
ing synaptic and nonsynaptic vesicle constituents. This type
of approach has already proven useful to identify the type
of membrane-bound organelle transported by KIF1A, an-
other member of the kinesin superfamily (Okada et al., 1995).
Approximately 70–80% of KIF2 and KHC were recov-
ered in the P3 (high speed pellet) fraction, while 
 
,
 
30%
were present in the P2 (medium speed fraction) and S3
(high speed supernatant) fractions. In the P3 microsome
fraction, KHC was recovered in a fraction that extends
from 0.3 to 0.6 M sucrose (Fig. 2). By contrast, KIF2 was
recovered in a different fraction extending from 0.4 to 0.9 M
sucrose, with a peak at 0.6–0.8 M sucrose (Fig. 2). The dis-
tribution of KIF2 across the sucrose density gradient was
then compared with that of synaptophysin and synapsin I,
two well-characterized synaptic vesicle (SV) membrane
proteins (Fletcher et al., 1991). The results obtained
showed that synaptophysin was recovered in lighter frac-
tions (0.3–0.6 M) than those enriched in KIF2, while syn-
apsin I was recovered in fractions extending from 0.6 to 1.0 M
sucrose (Fig. 2). The staining for synapsin I overlapped
with that of KIF2, but the peak fractions were different.
Next we compared the distribution of KIF2 with that of
three well-characterized growth cone membrane compo-
Figure 1. (A) Specificity of the affinity-purified peptide antibod-
ies against KIF2 as revealed by Western blot analysis of whole
tissue extracts from the cerebral cortex of 3-d-old rats reacted
with the BKF2 (diluted 1:100; lane 1), or RKF2 (diluted 1:100;
lane 3). Both antibodies stain a single immunoreactive protein
species with an apparent molecular weight of 97 kD. The staining
generated by these antibodies is completely abolished by neutral-
ization with the corresponding purified peptides (lanes 2 and 4).
20 mg of total protein was loaded in each lane. (B) The expression
of KIF2 in the developing rat cerebral cortex as revealed by
immunoblot analysis of whole tissue extracts. P1–P14, Post-natal
d 1–14; Ad, adult. KIF2 is highly expressed in the developing ce-
rebral cortex. The blot was reacted with RKF2 (dilution 1:100);
40 mg of total protein were loaded in each lane. (C) Western blot
analysis of subcellular fractions obtained from the cerebral cortex
of 3-d-old rats showing that KIF2 is highly enriched in the mi-
crosomal fraction (P3). CE, crude extract; S1, low speed superna-
tant; P1, pellet 1; S2, medium speed supernatant; P2, pellet 2; S3,
high speed supernatant; P3, pellet 3 or microsomal fraction. The
blot was reacted with RKF2 (dilution 1:100); 20 mg of protein was
loaded in each lane. (D) KIF2 precipitates with microtubules pre-
pared from cytosolic fractions of developing rat cerebral cortex
by the method of Vallee (1982; see Materials and Methods). The
presence of KIF2 or KHC in the microtubule pellet was then as-
sessed by Western blotting with the BKF2 (dilution 1:25) or SUK
4 (dilution 1:100) antibodies. CE, crude extract; CS, cytosolic
fraction; S, supernatant after microtubule pelleting in the pres-
ence of AMP-PNP; P, microtubule pellet obtained in the pres-
ence of AMP-PNP; S, supernatant fraction after microtubule
pelleting in the presence of ATP (10 mM); P, microtubule pellet
in the presence of ATP (10 mM); S, supernatant fraction after mi-
crotubule pelleting in the presence of ATP (10 mM) plus NaCl
(100 mM); P, microtubule pellet in the presence of ATP (10 mM)
plus NaCl (100 mM). Note that KIF2, as opposed to KHC, is only
slightly released from microtubules in the presence of ATP.
Figure 2. The binding of KIF2 to membrane vesicles. Microsome
fraction from developing rat cerebral cortex was fractionated by
sucrose gradient centrifugation, and the same volume from each
fraction was applied to SDS-PAGE, transferred to PVDF mem-
branes, and analyzed by immunoblotting with antibodies against
KHC, KIF2, synaptophysin (p38), synapsin I (Sin I), bgc, APP,
GAP-43, and N-cadherin (N-Cad). Note that the peak fractions
of KIF2 and bgc are highly coincident.Morfini et al. KIF2 Function in Developing Neurons 661
nents. One of them, designated bgc (a novel variant of the
b-subunit of the IGF-1 receptor, which is highly enriched
in growth cone membranes; Quiroga et al., 1995; Mascotti
et al., 1997), displayed a striking codistribution with KIF2,
being highly enriched in the 0.6–0.8 M sucrose fractions
(Fig. 2). On the other hand, GAP-43 (Goslin et al., 1989)
and APP (Ferreira et al., 1993; Yamazaki et al., 1995b) dis-
tributed across the sucrose gradient with a pattern clearly
different from that of KIF2 (Fig. 2). Thus, GAP-43 was re-
covered in all fractions of the sucrose gradient (0.3–1.6 M),
while APP was enriched in either lighter (0.3–0.6 M) or
heavier (1.0–1.6 M) fractions than those containing KIF2.
The pattern of distribution of N-cadherin, a cell-adhesion
molecule, was also compared with that of KIF2; this pro-
tein displayed a uniform distribution across the sucrose
gradient, showing no enrichment in the fractions contain-
ing KIF2 or bgc (Fig. 2).
Taken collectively, these observations confirm previous
studies suggesting the existence of at least two classes of
organelles that contain SV membrane proteins: one con-
tains synapsin I, and the other synaptophysin (Okada et
al., 1995). The former appears to be transported by KHC
(Ferreira et al., 1992), while the latter by KIF1A (Okada
et al., 1995). Our observations also suggest the existence of
another type of organelle that appears to contain a non-
synaptic growth cone membrane component, namely bgc,
and KIF2. However, because other KIFs (KHC, KIF1A,
and KIF3; Kondo et al., 1994; Okada et al., 1995) are also
present in these fractions, definite conclusions cannot be
drawn on the motor for the bgc-containing organelles. Be-
sides, the relationship between synaptophysin- and syn-
apsin I–containing organelles with the ones enriched in
KIF2 is also unclear, given that some degree of overlap ex-
ists among the fractions containing these proteins. There-
fore, to clarify some of these points and directly determine
the relationship between KIF2 and bgc, immunoisolation
of organelles from the microsomal fraction was performed
with antibodies against KIF2. The remaining organelles
were recovered by pelleting from the supernatant fraction.
Fig. 3 shows that with this method, the KIF2-containing
organelles were quantitatively collected. In this immu-
noisolated organelle fraction bgc was quantitatively recov-
ered (Fig. 3 A). In contrast, KHC (Fig. 3 B), synaptophysin
(Fig. 3 C), or synapsin (not shown) were not, or were only
slightly detectable in this fraction. These proteins were
quantitatively recovered in the remaining organelle frac-
tion. They were not detected in the supernatant fraction
after pelleting the remaining organelles, effectively ruling
out the possibility that the lack of these proteins in the
KIF2 organelle–containing fraction was due to dissocia-
tion during the immunoisolation procedure.
These results clearly and directly demonstrate that KIF2
is associated with a class of nonsynaptic, membranous or-
ganelle that contains bgc as one of its components. How-
ever, they do not provide evidence about the in vivo rela-
tionship between KIF2 expression and the transport of
bgc-containing organelles, and/or the functional role of
KIF2 during neuronal morphogenesis. Therefore, to ob-
tain evidence about these aspects we decided to examine
the pattern of expression and subcellular distribution of
KIF2, as well as the consequences of KIF2 suppression on
the distribution of bgc in PC12 cells. In this cell system, bgc
expression is upregulated by NGF and highly correlated
with neurite outgrowth. Even more importantly, in NGF-
treated PC12 cells, bgc is selectively concentrated in the
proximal growth cone region in vesicle-like structures,
clearly different from those containing synaptophysin or
synapsin I (Mascotti et al., 1997), a phenomenon that also
suggests that bgc may be transported to the growth cone
area by a motor different from KHC or KIF1A.
The Expression and Subcellular Localization of KIF2 in 
NGF-treated PC12 Cells
PC12 cells have proven to be an excellent model system
for studying growth cone formation, neurite outgrowth,
and the expression of structural and membrane proteins
involved in nerve cell morphogenesis (Drubin et al., 1985;
Greene et al., 1987; Bearer, 1992; Ezmaeli-Azad et al.,
1994; Mascotti et al., 1997). In the absence of NGF, PC12
cells have a round morphology with no neurites or growth
cone-like structures. Upon stimulation with NGF, they ex-
tend several neurites tipped by well-defined growth cones,
which are highly enriched with several SV and non-SV
membrane markers, such as synaptophysin and bgc (Mas-
cotti et al., 1997).
Fig. 4 shows that NGF induces the expression of KIF2 in
PC12 cells (Fig. 4, lanes 1 and 2). Thus, only one band of
about 100 kDa Mr is detected when whole cell extracts
from PC12 cells, cultured for 72 h in the presence of NGF,
are resolved in SDS-PAGE, blotted and immunostained
with the anti-KIF2 antibodies (Fig. 4, lane 2). At equiva-
lent, or even two to threefold higher protein loadings,
KIF2 is barely detectable in cell extracts from PC12 cells
cultured without NGF (Fig. 4, lane 1). In addition, if NGF-
differentiated (4 d) PC12 cells are deprived of the neu-
rotrophin for 6–12 h, neurite length decreases significantly
(see Mascotti et al., 1997), as do KIF2 protein levels (Fig.
4, lane 3). These results showed that, in PC12 cells KIF2
expression (as in the case of bgc; Mascotti et al., 1997) is
tightly controlled by NGF as well as differentiation.
In the next series of experiments the spatial distribution
of KIF2 was studied by double immunolabeling with the
BKF2 antibody and an mAb that recognizes tyrosinated
Figure 3. Immunoisolation
of  bgc-containing organelles
with the BKF2 antibody (di-
lution 1:20). Lane 1, mi-
crosome fraction before im-
munoprecipitation. Lanes 2
and  3, microsome fraction in-
cubated with BKF2 preim-
mune serum—pellet (lane 2)
and remanent organelles
(lane  3). Lanes 4 and 5, mi-
crosome fraction incubated
with BKF2—pellet (lane 4)
and remanent organelles (lane 5). Each of these fractions was ap-
plied to SDS-PAGE, transferred to PVDF membranes, and ana-
lyzed by immunoblotting with antibodies against bgc, KHC, or
synaptophysin. Note that bgc, but not KHC or synaptophysin
(p38) is quantitatively recovered in the immunoisolated fraction
(lane 4); only a faint band is detected in the remanent organelle
fraction (lane 5).The Journal of Cell Biology, Volume 138, 1997 662
a-tubulin (clone TUA 1.2). PC12 cells cultured in the ab-
sence of NGF have a round or polygonal morphology (Fig.
5 A, tubulin antibody), and exhibit very weak immunoflu-
orescence when incubated with the KIF2 antibody (Fig. 5
B). As expected, a significant increase in KIF2 immunoflu-
orescence becomes evident when PC12 are cultured in the
presence of NGF. This phenomenon is detected z48 h af-
ter the addition of NGF, when PC12 cells begin to acquire
a neuron-like morphology. At this stage, the cells have
several short neurites tipped with small growth cones.
KIF2 immunofluorescence is preferentially localized to
the perinuclear region and to the growth cones (Fig. 5 D;
compare with tubulin staining in Fig. 5 C). An exception is
the occasional short neurites that contain a continuous
band of granular staining between the perinuclear region
and the growth cones. After 72 h in the presence of NGF,
PC12 cells have extended several long neurites that ended
in prominent growth cones. At this stage KIF2 immuno-
staining has become very intense within the growth cone
area, but has disappeared completely from neuritic shafts;
a similar pattern is detected in PC12 cells cultured with
NGF for longer periods of time (3–7 d). Observation of
the growth cones at high magnification demonstrates that
KIF2 staining labels a punctate organelle pattern (Fig. 5, E
and F).
Antisense Oligonucleotides Affect KIF2 Expression
Three phosphorothioate (S-modified) antisense oligonu-
cleotides were tested for their ability to inhibit KIF2 ex-
pression. PC12 treated with NGF for 3 d and incubated for
24 h with each of the antisense oligonucleotides (5 mM
dose) described in Materials and Methods show markedly
reduced reactivity to the RKF2 antibody, as assessed by
Western blotting of whole cell extracts (Fig. 6 A; Table I).
In contrast, cells treated with sense oligonucleotides are
comparable in their immunoreactivity to untreated control
cells (Fig. 6 A). Exposure to the antisense oligonucleotides
did not affect tubulin (Fig. 6 A), KHC (Fig. 6 B), dynein
(not shown), bgc (Fig. 6 C), or synaptophysin (Fig. 6 D) im-
munoreactivity by the same assay. The presence of normal
levels of these proteins in the KIF2-suppressed cells sug-
gests that the effect of the antisense treatment is specific
and that the regulation of the expression of other motor
proteins (e.g., KHC or dynein) is independent of KIF2.
Distribution of bgc in Antisense-treated Neurons
Next we examined the distribution of bgc, synaptophy-
sin, synapsin I, GAP-43, and APP in control and KIF2 an-
tisense oligonucleotide-treated PC12 cells. As expected,
KIF2 immunofluorescence is significantly reduced in dif-
ferentiated PC12 cells treated with the ASKF2a or ASKF2b
antisense oligonucleotides (not shown). A dramatic alter-
ation in the distribution of bgc is also detected (Fig. 7).
Thus, while in nontreated or sense-treated differentiated
control PC12 cells bgc is selectively and highly enriched at
growth cones (Fig. 7, A and B), in the KIF2 antisense-
treated cells, all of the labeling is present within the cell
body, being completely absent from neuritic shafts includ-
ing their tips (Fig. 7, C–F). By contrast, the distribution of
synaptophysin, synapsin I, APP, and GAP-43 is unaltered
in the KIF2 antisense-treated cells when compared with
that observed in the control cells (nontreated or sense-
treated); thus, all of these proteins are highly concentrated
within the perinuclear region, presumably the Golgi com-
plex, and the growth cones (Figs. 8, A–H, and 9, A and B).
To determine if other motors may participate in bgc
transport, cells were treated with KHC antisense oligonu-
cleotides. As shown in Fig. 9, KHC suppression does not
alter the distribution of bgc (Fig. 9, C and D); however, and
as previously described (see Ferreira et al., 1993; Yamazaki
et al., 1995b) this treatment produces a dramatic reduction
of APP immunolabeling at the growth cone and a concom-
itant accumulation within the cell body (Fig. 9, C and D).
Effect of KIF2 Antisense Oligonucleotides on
Neurite Extension 
During the course of these experiments it became evident
that one additional effect of KIF2 suppression was a re-
duction in the length of PC12 neurites. Therefore, to pre-
cisely examine this effect, neurite extension was measured
in NGF-treated PC12 cells after either a 24- or a 36-h ex-
posure to the KIF2 antisense oligonucleotides. When
PC12-treated with NGF for 3 d are exposed to the
ASKF2a antisense oligonucleotide (5 mM) and fixed 24 h
later there is a slight decrease in neurite length. In the anti-
sense-treated cultures, the mean total neurite length per
cell is 225 6 5 mm, a value lower than that observed in
control (260 6 8 mm) or sense-treated (265 6 8 mm) cells.
Neurite length in neurons exposed to KIF2 antisense oli-
gonucleotides (5 mM) for 36 h is quantitated in Table II.
These cells exhibit a 60–70% decrease in neurite length.
Our observations also show that the KIF2 antisense oligo-
nucleotides affected neurite outgrowth in a dose-depen-
dent manner; thus, at 2.5 mM the total neurite length was
reduced 35% and at 1 mM it was only reduced 15% (Table
II). While suppressing KIF2 expression, the KIF2 anti-
sense oligonucleotides did not irreversibly damage the
neurons. When, after 36 h in the presence of the antisense
Figure 4. KIF2 expression in
PC12 cells. Immunoblot analy-
sis of whole cell extracts from
nontreated (lane 1) or NGF-
treated (lane 2) PC12 cells re-
acted with the BKF2 antibody
(dilution 1:50). NGF induces
the expression of a single KIF2
immunoreactive protein spe-
cies with an apparent molecu-
lar mass of 97 kD. Note that
KIF2 is barely detected in un-
differentiated PC12 cells.
When NGF-differentiated PC12
cells were deprived of the neu-
rotrophin for 6 h, KIF2 be-
comes considerably less abun-
dant (lane 3) than in control
ones (lane 2). 40 mg of protein
were loaded in each lane and
the immunoblots were re-
vealed using a rabbit Proto-
Blot (Promega) staining kit.
PC12 cells were treated with
NGF (50 ng/m) for 3 d.Morfini et al. KIF2 Function in Developing Neurons 663
oligonucleotides, the cells are released from antisense in-
hibition by changing the medium, neurite extension re-
sumed at a rate that paralleled that observed under con-
trol conditions (see below).
In the final set of experiments, we used quantitative flu-
orescence and the morphometry of fixed cells to analyze
expression of KIF2 and compare it with both the time
course of bgc disappearance from the growth cone area,
and the reduction of neurite length in PC12 cells treated
with the ASKF2a antisense oligonucleotide for different
periods of time. The results obtained show that the de-
crease in KIF2 immunofluorescence precedes the disap-
Figure 5. KIF2 becomes lo-
calized to growth cones in
differentiated PC12 cells.
Double immunofluorescence
micrographs showing the dis-
tribution of tyrosinated a-tubu-
lin (A, C, and E) and KIF2
(B, D, and F) in PC12 cells.
PC12 cells, cultured in the
absence of NGF, display low
positive immunofluorescence
for the RKF2 antibody (A
and  B). A dramatic increase
in KIF2 immunofluorescence
is detected in PC12 cells
treated with NGF for 2 d. In
these cells, KIF2 is localized
to the perinuclear region and
highly enriched in growth
cones (arrowheads). High
power micrographs of neu-
ritic tips reveal a granular
(vesicle-like) appearance of
the KIF2 immunostaining
(F). Bars: 10 mm.The Journal of Cell Biology, Volume 138, 1997 664
pearance of bgc from the growth cone area, a phenomenon
which in turn precedes the decrease in neurite length by
several hours (Fig. 10, A and B). Similarly, when the cells
are released from the antisense treatment the reexpression
of KIF2 precedes the redistribution of bgc to the growth
cone, a phenomenon which is then followed by an increase
in neurite length (Fig. 10, A and B).
Discussion
KIF2 and the Subcellular Distribution of bgc
The present results confirm and extend previous observa-
tions by Noda et al. (1995) suggesting that KIF2 is an an-
terograde microtubule-based motor involved in the trans-
port of a class of nonsynaptic membrane organelles
abundant in developing neurons. The new information
presented here suggests that at least one of the compo-
nents transported by KIF2 is bgc, a growth cone nonsynap-
tic membrane protein (Quiroga et al., 1995; Mascotti et al.,
1997). Thus, one striking finding in KIF2-suppressed PC12
cells is the altered distribution of bgc. In untreated cells, or
cells treated with sense oligonucleotides, bgc is found se-
lectively concentrated within growth cones. In antisense-
treated cells, on the other hand, bgc is confined to the cell
body.
Several observations suggest that this effect is the result
of a specific and selective blockade of KIF2 expression by
the antisense treatment. First, sequence analysis of the re-
gions of the KIF2 mRNAs selected for designing the anti-
sense oligonucleotides reveals no significant homology with
any other reported sequence, including other members of
the kinesin superfamily. In addition, none of the S-modi-
fied antisense oligonucleotides used in this study contains
four contiguous guanosine residues, which are believed to
increase oligomer affinity to proteins, and hence generate
nonspecific antisense inhibitory effects (Wagner, 1995).
Secondly, the antisense oligonucleotide treatment dramat-
ically reduces KIF2 protein levels without altering the lev-
els of several other proteins including tubulin, KHC, dy-
nein, synaptophysin, GAP-43, and bgc; this is important
since some of these proteins have been directly implicated
in neurite formation (Yankner et al., 1990; Ferreira et al.,
1992). Third, the effects of the antisense oligonucleotides
are dose dependent and not observed when the cells are
treated with equivalent doses of the corresponding sense
oligonucleotides. In addition the effects are also observed
when the antisense oligonucleotides are used at very low
concentrations (2.5 mM), a phenomenon which also con-
tributes to rule out the possibility of nonspecific binding of
the oligonucleotides to proteins (Wagner, 1995). Fourth,
the antisense treatment does not cause irreversible dam-
age to the cells; PC12 cells recover the normal distribution
of bgc following a change to medium free of the antisense
oligonucleotide. Fifth, KIF2 suppression selectively alters
bgc distribution without affecting the subcellular localiza-
tion of several other growth cone components, including
synaptophysin, synapsin I, APP, and GAP-43, which are
transported to the neurite terminus by other microtubule-
based anterograde motors, such as KIF1A and KHC (Fer-
reira et al., 1992, 1993; Okada et al., 1995). Conversely, the
distribution of bgc is not modified by KHC antisense oligo-
nucleotides, a treatment that significantly disrupts the
growth cone localization of APP (Ferreira et al., 1993;
Yamazaki et al., 1995b; this study) or GAP-43 (Ferreira et
al., 1992).
Several additional lines of evidence also support the
Figure 6. Effect of the KIF2 antisense oligonucleotide ASKF2a
(5 mM) on KIF2 (A), tyrosinated a-tubulin (A), KHC (B), bgc
(C), and synaptophysin (D) protein levels as revealed by Western
blot analysis of whole cell homogenates obtained from PC12
cells. For this experiment PC12 cells cultured in the presence of
NGF were treated for 24 h with the ASKF2a oligonucleotide.
Antisense treatment was initiated 3 d after the addition of NGF
(50 ng/ml). Control cultures were treated with equivalent doses
of sense oligonucleotides. (A) Blot reacted with antibodies
against KIF2 (RKF2 diluted 1:50) and tyrosinated a-tubulin
(mAb TUB-1A2), or with mAb SUK 4 (B), or with an affinity-
purified polyclonal antibody against bgc (C), or with mAb SY38
(D). 30 mg of total cellular protein were loaded in each lane.
Blots were revealed using the ProtoBlot staining kit (Promega).
Table I. Effect of KIF2 Antisense Oligonucleotides on KIF2 
and Tubulin Protein Levels in NGF-treated PC12 Cells
Group KIF2 Tubulin
Nontreated 2,750 6 200 5,500 6 150
Sense-treated
MKF2-11/114 (50 mM) 2,800 6 150 6,000 6 180
ASMKF2 (50 mM) 211/114 250 6 50* 5,700 6 250
Sense-treated SKF2a (5 mM) 2,650 6 150 5,600 6 220
ASKF2a (5 mM) 310 6 60* 5,850 6 120
ASKF2a (2.5 mM) 740 6 80* 5,700 6 150
ASKF2b (5 mM) 280 6 40* 5,700 6 100
PC12 cells were cultured in the presence of NGF (50 ng/ml). On the third day after the
addition of NGF, the cells were treated with KIF2 sense or antisense oligonucleotides
for a 24-h period.
KIF2 and tubulin protein levels were analyzed by quantitative immunoblotting with
125I-protein A; autoradiographs were aligned with immunoblots, and KIF2 protein lev-
els were quantitated by scintillation counting of nitrocellulose blot slices. 10 mg of to-
tal cellular protein was used for each sample.
Each value represents the mean 6 SEM; they are expressed in cpm.
*Values significantly different from those found in control samples.Morfini et al. KIF2 Function in Developing Neurons 665
idea that KIF2 may serve as the plus-end motor involved
in the anterograde transport of bgc-containing vesicles.
First, analysis of subcellular fractions obtained by SDG
centrifugation of microsomal fractions revealed a striking
colocalization of KIF2 with bgc. Second, and even more
important, immunoisolation experiments allow us to iso-
late the KIF2 cargo from other organelles and determine
that the KIF2 cargo contained bgc, but lacked synapto-
physin, synapsin I, and KHC. Third, both KIF2 and bgc are
predominantly expressed in developing brain tissue, up-
regulated by NGF, and highly enriched in growth cone
membrane preparations obtained from fetal brain tissue
(Noda et al., 1995; Quiroga et al., 1995). Finally, immuno-
fluorescence studies show that within growth cones bgc as-
sociates with a type of vesicle-like structure different from
those containing synaptophysin and synapsin I (Mascotti
et al., 1997).
The present observations also support the notion that in
developing neurons KIF2 function is significantly different
from the one performed by other members of the central
motor domain subfamily in nonneuronal cells. Thus, all
other KIF2-related proteins have been implicated in mito-
sis and spindle elongation (Wordeman and Mitchison,
1995; Walczak et al., 1996). While this seems to be an un-
expected finding, it is worth noting that divergence in
function among filogenetically related kinesin superfamily
members may not be an unusual phenomenon. In fact, a
similar situation exists in the case of KIFC2 that, unlike
other COOH-terminal kinesin related proteins of the
KAR3 family involved in mitosis and meiosis, appears to
participate in the retrograde transport of a subpopulation
of membrane bound organelles present in neuronal cells
(Hanton et al., 1997; Saito et al., 1997). It will now be of
considerable interest to begin analyzing the nature of this
functional divergence.
KIF2 Participation in Neurite Extension
Analysis of the in situ distribution of KIF2 revealed that it
is expressed in postmitotic neurons and concentrated in
axonal processes of developing neurons (Noda et al.,
1995). The present study extends these observations by
showing that KIF2 expression is upregulated by environ-
mental factors such as NGF and that its induction profile
Figure 7. KIF2 suppression
alters the distribution of bgc
in NGF-differentiated PC12
cells. (A and B) Double
immunofluorescence micro-
graphs showing tubulin (A)
and bgc (B) staining in PC12
cells from a culture treated
with a KIF2 sense oligonu-
cleotide (5 mM). Note that
bgc immunofluorescence is
preferentially localized at
neuritic tips (arrowheads). (C
and D) Double immunofluo-
rescence micrographs show-
ing tubulin (A) and bgc ( B )
staining in PC12 cells from a
culture treated with ASKF2a
oligonucleotide (5 mM). Note
the complete disappearance
of bgc from neuritic tips (ar-
rowheads). For these experi-
ments, cells were cultured in
serum-free medium in the
presence of NGF (50 ng/ml).
On day 3, after the addition
of NGF, the cells were
treated with KIF2 antisense
or sense oligonucleotides for
a 24-h period; they were then
fixed and processed for im-
munofluorescence as de-
scribed in Materials and
Methods. Bar, 10 mm.The Journal of Cell Biology, Volume 138, 1997 666
closely parallels neurite extension in PC12 cells. Further-
more, NGF withdrawal not only causes neurite retraction,
but also a precipitous drop in KIF2 protein levels. It fol-
lows that KIF2 expression is strictly regulated by NGF and
thus, is a differentiation product of PC12 cells; in contrast
to KHC, which is expressed in proliferative and non-pro-
liferative cells (Feiguin et al., 1994). The upregulation of
KIF2 expression in NGF-treated PC12 cells puts this mol-
Figure 8. KIF2 suppression alters the distribution of bgc, but not of synaptophysin, GAP-43, or synapsin I in NGF-treated PC12 cells.
(A–D) Double immunofluorescence micrographs showing the distribution of bgc (A and C), synaptophysin (B), and GAP-43 (D) in
NGF-differentiated PC12 cells treated with a KIF2 antisense oligonucleotide (ASKF2a, 5 mM). Note that while bgc completely disap-
pears from growth cones (arrows), synaptophysin and GAP-43 remain highly concentrated at neuritic tips. (E and F) Double immuno-
fluorescence micrographs showing the distribution of tyrosinated a-tubulin (E) and synapsin I (F) in NGF-differentiated PC12 cells
treated with ASKF2a (5 mM). Note that synapsin I is highly concentrated at neuritic tips. For these experiments, cells were treated with
oligonucleotides as described in Fig. 7. Bar, 10 mm.Morfini et al. KIF2 Function in Developing Neurons 667
Figure 9. (A and B) Double
immunofluorescence micro-
graphs showing the distribu-
tion of bgc (A) and APP (B)
in NGF-differentiated PC12
cells treated with the KIF2
antisense oligonucleotide
ASKF2b (5 mM). Note that
while bgc completely disap-
pears from growth cones (ar-
rowheads) APP remains
highly concentrated at neu-
ritic tips. (C and D) Double
immunofluorescence micro-
graphs showing the distribu-
tion of bgc (C) and APP (D)
in NGF-differentiated PC12
cells treated with the KHC
antisense oligonucleotide -11/
14 hkin (50 mM). Note that
while this treatment does
not affect the growth cone lo-
calization of bgc, it dramati-
cally decreases APP immuno-
fluorescence at neuritic tips.
For these experiments, cells
were treated with antisense
oligonucleotides as described
in Fig. 7. Bar, 10 mm.
ecule in a similar category to MAP1b and tau—two struc-
tural MAPs whose expression is induced by NGF (Drubin
et al., 1985; Aletta et al., 1988), and that have been directly
implicated in neurite extension in PC12 cells (Brugg et al.,
1993; Esmaeli-Azad et al., 1994). The analysis of the phe-
notype of KIF2-suppressed PC12 cells provides direct evi-
dence about its participation in neurite extension; thus, a
24- or 36- h exposure to KIF2 antisense, but not sense, oli-
gonucleotides results in a significant reduction in neurite
length. Interestingly, neurite growth is also impaired in
KHC-suppressed neurons, a phenomenon which has been
related with the blockade of the anterograde transport of
the growth cone regulatory protein, GAP-43 (Ferreira et
al., 1992).
While the mechanism(s) by which KIF2 participates in
neurite extension are currently unknown, one obvious
possibility, as in the case of KHC, relates with the nature
and final destination of the cargo that it transports. For ex-
ample, the KIF2 cargo may contain regulatory proteins
that when appropriately delivered to the growth cone will
actively participate in neurite outgrowth. Such cargo types
may include receptor proteins for certain types of neurito-
genic factors, as it might be the case for the bgc-containing
IGF-1 receptors. In this regard, one question that arises
concerns the possible relationship between the altered dis-
tribution of bgc and the inhibition of neurite outgrowth ob-
served in KIF2-suppressed PC12 cells.
IGF-1 appears to function in most cells primarily as a
mitogenic peptide, but in the particular case of the devel-
oping nervous system it also functions as a neurotrophic
factor promoting neurite outgrowth (Aizenmann and De
Vellis, 1987; Caroni and Grandes, 1990; Beck et al., 1993;
Ishii et al., 1993). The receptor for IGF-1 resembles the in-
sulin receptor, and is a disulfide-linked heterotetrameric
(a2b2) transmembrane glycoprotein, with extracellular
Table II. Effect of KIF2 Antisense Oligonucleotides on Neurite 
Length in NGF-treated PC12 Cells
Group
Mean total neurite
length per cell
Number of
neurite per cell
Control 295 6 8 4.0 6 0.2
Sense-treated 310 6 6 4.0 6 0.3
ASKF2a (5 mM) *110 6 5 3.5 6 0.3
ASKF2a (2.5 mM) *200 6 10 3.8 6 0.2
ASKF2b (5 mM) *105 6 12 3.4 6 0.2
ASKF2b (2.5 mM) *210 6 10 3.8 6 0.1
ASKF2b (1 mM) 260 6 14 4.0 6 0.1
PC12 cells were cultured in the presence of NGF (50 ng/ml). On the third day after the
addition of NGF, the cells were treated with KIF2 sense or antisense oligonucleotides
for a 36-h period. They were then fixed and processed for immunocytochemistry
(double labeling with tubulin and KIF2 antibodies). Mean total neurite length and the
mean number of neurites per cell was evaluated using the morphometric menu of the
Metamorph system (see Materials and Methods).
Neurite length values are expressed in mm. A total of at least 250 cells was measured
for each experimental condition. Each value represents the mean 6 SEM.
*Values significantly different from those found in control cells. The Journal of Cell Biology, Volume 138, 1997 668
ligand-binding (a) and intracellular tyrosine kinase (b) do-
mains (Ullrich et al., 1986). The expression of IGF-1 re-
ceptors in the nervous system is high at late embryonic and
early postnatal stages and declines significantly afterwards
(Ullrich et al., 1986; Werner et al., 1991), again suggesting
an important role for this ligand-receptor system in brain
development. Interestingly, IGF-1 and its receptor, as well
as KIF2, are expressed permanently in the olfactory bulb
where neuronal remodeling and neurite outgrowth con-
tinue throughout adult life (Bondy, 1991; Noda et al.,
1995); and transgenic mice lacking IGF-1 receptors exhibit
serious deficits in neural development (Liu et al., 1993).
In developing neurons, the expression of bgc-containing
IGF-1 receptors, but not of other b subunits (bother) of the
insulin or IGF-1 receptors, is correlated with neurite out-
growth, growth cone formation, and (in PC12 cells) is
highly dependent on NGF (Mascotti et al., 1997). Taken
together, these observations raised the idea that the differ-
ent functions of IGF-1 (mitogenic or neuritogenic actions)
may result from the contrasting regulations and distribu-
tions of bgc-containing IGF-1 versus bother-containing insu-
lin/IGF-1 receptors in developing neurons. Thus, an al-
tered distribution of bgc-containing IGF-1 receptors is
compatible with the reduction of neurite length observed
in KIF2-suppressed neurons. In this regard, it is worth not-
ing that the disappearance of bgc from growth cones pre-
cedes the reduction in neurite length; the opposite phe-
nomenon was not observed under the present experimental
conditions. However, definite conclusions on this matter
will certainly depend on a more detailed characterization
of the biological role of bgc-containing IGF-1 receptors as
well as of the identification of other components present
in the KIF2-transported cargo. Given that other members
of the central motor domain subfamily are involved in
spindle elongation (Walczak and Mitchison, 1996), it will
also be of interest to explore the possible participation of
KIF2 in the regulation of microtubule organization and/or
dynamics. Studies are in progress to address these and re-
lated issues.
This paper is dedicated to NIS and MFM.
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